Current status of umbilical cord blood hematopoietic stem cell transplantation

Experimental Hematology

Volumn 28, Issue 11, 2000, Pages 1197-1205

  Gluckman, Eliane ^a  

^a SAINT LOUIS HOSPITAL   (France)

Author keywords

Umbilical cord blood allogeneic transplant

Indexed keywords

ACUTE LEUKEMIA; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; BONE MARROW DISEASE; CANCER; CHILD; CLINICAL TRIAL; COMPLICATION; DONOR; GRAFT PATENCY; GRAFT VERSUS HOST REACTION; HISTIOCYTIC LYMPHOMA; HLA MATCHING; HUMAN; IMMUNE DEFICIENCY; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; METABOLIC DISORDER; MULTICENTER STUDY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SICKLE CELL ANEMIA; STATISTICAL ANALYSIS; STEM CELL TRANSPLANTATION; SURVIVAL; THALASSEMIA; TREATMENT OUTCOME; UMBILICAL CORD BLOOD;

ADULT; FETAL BLOOD; FETAL TISSUE TRANSPLANTATION; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; SUPPORT, NON-U.S. GOV'T;

EID: 0033786310     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-472X(00)00540-3     Document Type: Review

References (34)

1. Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical cord blood from an HLA-identical sibling
2. Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution
3. Stored placental blood for unrelated bone marrow reconstitution
4. Outcome of cord blood transplantation from related and unrelated donors
5. Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients
6. Successful transplantation of HLA matched and HLA mismatched umbilical cord blood from unrelated donors; analysis of engraftment and acute graft versus host disease
7. Outcomes among 562 recipients of placental blood transplants from unrelated donor
8. Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings
9. Factors influencing the outcome of bone marrow transplants using unrelated donors
10. High resolution HLA matching associated with decreased mortality after unrelated bone marrow transplantation
11. Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia
12. Optimizing outcome after unrelated marrow transplantation by comprehensive matching of HLA Class I and II alleles in the donor and the recipient
13. Effect of matching of class I HLA alleles on clinical outcome after transplantation of hematopoietic stem cells from an unrelated donor
14. Outcomes of transplantation with matched-sibling and unrelated donor bone marrow in children with leukemia
15. A phase I-II clinical trial to evaluate removal of CD4 cells and partial depletion of CD8 cells from donor marrow for HLA-mismatched unrelated recipients
16. Children with acute lymphoblastic leukemia who receive T-cell depleted HLA mismatched marrow allografts from unrelated donors have an increased incidence of primary graft failure but a similar overall transplant outcome
17. Unrelated donor bone marrow transplantation for children with relapsed acute lymphoblastic leukaemia in second complete remission
18. Successful engraftment of T-cell depleted haploidentical three loci incompatible transplants in leukemia patients by addition of recombinant human granulocyte colony stimulating factor mobilized peripheral blood progenitor cells to bone marrow inoculum
19. Treatment of high risk acute leukemia with T cell depleted stem cells from related donors with one fully mismatched HLA haplotype
20. Allogeneic transplantation from donors other than HLA identical siblings
21. Hematopoietic content of cord blood
22. Does cord blood transplantation result in lower graft versus host disease? It takes more than two to Tango
23. The umbilical cord blood αβ T cell repertoire; characteristics of a polyclonal and naive but completely formed repertoire
24. Cord blood T cell immunology
25. Placental and/or umbilical cord blood an alternative source of haemopoietic stem cells for transplantation
26. Differential cytotoxicity of cord blood and bone marrow-derived natural killer cells
27. Newborn blood can engraft adult mice without inducing graft versus host disease across non H-2 antigens
28. Graft versus host disease and graft versus leukemia effect in mice grafted with newborn blood
29. Recipient tumor necrosis factor-alfa and interleukin-10 gene polymorphisms associate with early mortality and acute graft versus host disease severity in HLA-matched sibling bone marrow transplants
30. Comparison of graft-versus-host disease in children transplanted with HLA identical sibling umbilical cord blood versus HLA identical sibling bone marrow transplant
31. Factors associated with outcome after cord blood transplantation in children with acute leukemia
32. Transplantation of marrow cells from unrelated donors for treatment of high-risk acute leukemia; the effect of leukemic burden, donor HLA-matching, and marrow cell dose
33. Simultaneous cord blood transplantation of ex-vivo expanded together with non-expanded cells for high-risk leukemia
34. Detection of maternal cells in human fetal blood during the third trimester of pregnancy using allele specific PCR amplification